Skip to content
Review Open access

Cerebral Intramural Cells: A Missing Cellular Link Between Vascular Aging and Alzheimer’s Disease

Aug 2026 · International Journal of Molecular Sciences · Vol 27 · 0 citations · 178 references
Medicine

TL;DR

A CIC-centered framework may help explain the links between vascular dysfunction, impaired Aβ clearance, and neurodegeneration in AD and CAA.

Abstract

The pathological deposition of amyloid-β (Aβ) in the walls of cerebral blood vessels as cerebral amyloid angiopathy (CAA) is a key feature of Alzheimer’s disease (AD) and is linked to impaired clearance of Aβ via intramural periarterial drainage (IPAD). The spontaneous contractions of cerebral smooth muscle cells (SMCs) are thought to drive IPAD, but the relationship between vascular aging and Aβ accumulation remains unclear. We propose a unified framework centered on cerebral intramural cells (CICs), including arterial SMCs, specialized pericyte subtypes, as mediators of vascular dysfunction and neurodegeneration. We integrate current evidence from studies of cerebral small vessel disease, blood–brain barrier (BBB) dysfunction, pericyte biology, vascular aging, cerebral perfusion, and IPAD. CICs regulate vasomotion, capillary flow, BBB integrity, and IPAD. Their dysfunction impairs perfusion and protein clearance, increasing vulnerability in white matter and the hippocampus. These vascular alterations interact with amyloid and inflammatory processes, contributing to synaptic dysfunction, network disconnection, and neurodegeneration. CICs represent potential therapeutic targets. A CIC-centered framework may help explain the links between vascular dysfunction, impaired Aβ clearance, and neurodegeneration in AD and CAA.

Read PDF

Similar papers

Review Open access Sep 2026

Blood–brain barrier dysfunction and peripheral immune activation in Alzheimer’s disease: an inflammation-centered review

An inflammation-centered model is proposed in which BBB breakdown and peripheral immune dysregulation form a pathogenic loop that accelerates neurodegeneration, and targeting this BBB–peripheral immune axis may provide new opportunities for biomarker development, patient stratification, and combination therapy beyond c...

Zu-Li Yang, Zhi-Qiang Xiao, Bin Huang et al. · 0 citations
Review Open access Aug 2026

Astrocyte–blood–brain barrier crosstalk in cerebral small vessel disease: linking barrier dysfunction to neurovascular failure

Cerebral small vessel disease (CSVD) is a heterogeneous group of disorders involving the cerebral microvasculature and is a major cause of stroke and vascular cognitive impairment. The role of blood–brain barrier (BBB) dysfunction in CSVD is now recognized as a key pathological process; however, conventional vascular r...

Mei Xie, Shuang Wu, Ling Yang et al. · 0 citations
Review Aug 2026

Calcium dysregulation in neurovascular function in Alzheimer's disease: mechanisms, therapeutic targets.

A systematic review of physiological Ca2+ handling mediated by plasma membrane channels, transporters, and intracellular organelles in the cerebral vasculature emphasizes Ca2+ signaling as a promising therapeutic target to break the vicious cycle of neurovascular impairment and neurodegeneration in AD.

Yvan Hanscom-Trofy, Andrew Gregory, Gilbert C. Morgan et al. · 0 citations
Review Open access Aug 2026

Microglia-mediated neuroinflammation in Alzheimer’s disease: mechanisms and emerging therapeutic targets

A “cellular state–pathological network–therapeutic window” framework is proposed and the roles of microglia in amyloid-β plaque seeding and compaction, NLRP3 inflammasome activation, mitochondrial DNA–cGAS–STING signaling, complement-mediated synaptic engulfment, and bidirectional microglia–tau feedback are systematica...

Lian-Jing Xu, Ying Zhang, Li Jiang et al. · 0 citations
Open access Sep 2026

Regional choroid plexus calcifications and their associations with aging, brain structure, and disease

The choroid plexus (CP) maintains brain homeostasis through cerebrospinal fluid production and formation of the blood-cerebrospinal fluid barrier, and its dysfunction has been linked with aging and neurological disease. CP dysfunction may involve both enlargement and calcific tissue change, which may reflect distinct p...

Iyad Ba Gari, A. Zhu, Ravi R. Bhatt et al. · 0 citations
Review Aug 2026

Aging at the neurovascular interface: an integrative framework linking cardiovascular and cerebrovascular diseases.

Aging is a fundamental driver of cardiovascular and cerebrovascular comorbidities, yet the mechanisms linking aging to concurrent heart and brain diseases remain incompletely understood. The neurovascular interface (NVI) refers to the structural and functional interface through which neural, vascular, and extracellular...

Ke-Xin Chen, Jun Ma, Yong Peng · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.